Blocking blood flow during pancreatic tumor removal
Official title: A Prospective Study of Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery
Run by Zhejiang University · NCT06164769 · Data updated 2026-11-12
This study is testing a new way to remove certain pancreatic tumors while reducing bleeding and protecting healthy tissue in patients with benign or borderline tumors.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years to 70 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | March 1, 2023 |
| Main results expected | May 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | June 2, 2025 |
| Trial ID | NCT06164769 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with benign or borderline pancreatic tumors located in the head, neck, or uncinate process of the pancreas.
✕Probably not a fit
Patients with highly malignant tumors or those located in the body and tail of the pancreas will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a novel technique for laparoscopic enucleation of pancreatic tumors by blocking the abdominal trunk and superior mesenteric artery to minimize intraoperative bleeding. The approach aims to preserve healthy pancreatic tissue and reduce the risk of tumor recurrence. Conducted at the Second Affiliated Hospital of Zhejiang University, the study will include patients with benign or borderline pancreatic tumors located in the head, neck, or uncinate process of the pancreas. Data on clinical, biochemical, and radiological characteristics will be collected and analyzed throughout the study period from March 2023 to May 2026.
Why it matters
Potential benefit: If successful, this method could lead to safer surgical procedures with less blood loss and better preservation of pancreatic function.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in reducing surgical complications associated with pancreatic surgeries.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Benign or borderline tumors diagnosed pathologically, such as pancreatic neuroendocrine tumors, solid pseudopapillary tumors, and cystadenomas, without vascular invasion or distant metastasis * Tumors sited in the pancreatic head, neck, and uncinate process of pancreas * Blockade of both the abdominal trunk and superior mesenteric artery in the laparoscopic enucleation Exclusion Criteria: * Highly malignant pancreatic tumors, or tumors with infiltration or metastasis * Tumors of the body and tail of the pancreas * Transfer to LPD or laparotomy
Where it's running
-
the Second Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Principal investigator: Bo Zhou, Dr. — The Second Affiliated Hospital, Zhejiang Chinese Medical University
- Study coordinator: Sheng Yan, professor
- Email: shengyan@zju.edu.cn
- Phone: +86-13957161680
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bleeding control after single-ray amputation: Hemocoll vs Avitene vs bone wax
This trial tests whether Hemocoll, Avitene, or bone wax better stop bleeding from exposed bone after a planned single-ray amputation in adults.
-
Comparing periarticular vasoconstrictor infiltration and erector spinae plane block to reduce bleeding and pain in lumbar fusion
This trial will try periarticular vasoconstrictor infiltration versus erector spinae plane block to see if one reduces blood loss and postoperative pain in adults having lumbar fusion surgery.
-
Preventing bleeding during myomectomy with misoprostol
This will test whether giving misoprostol before myomectomy reduces surgical bleeding in women aged 18–43 having surgery for symptomatic uterine fibroids.
-
Using the HistoSonics Edison System to treat pancreatic cancer
This study is testing a new treatment using the HistoSonics Edison System to see if it can safely destroy tumors in patients with advanced pancreatic cancer that can't be removed by surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.